Quan Capital is a healthcare focused venture capital firm.
Quan Capital discover, incubate and grow next-generation life sciences companies. Their unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Their portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significant value to patients. In addition, they are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 20, 2022
Yuanyin Bio
|
Series A | ¥280M | Biopharma | — |
Nov 29, 2021
Yuanyin Bio
|
Seed | ¥100M | Biopharma | Yes |
Oct 3, 2019
Arcellx
|
Series B | $85M | Biopharma | Yes |